eFFECTOR Therapeutics Inc (EFTR)

Finanzdaten der eFFECTOR Therapeutics Inc-Aktie (EFTR)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	0.675
Operating Expenses	9.46% 8.598	7.855	7.855	9.536	9.398
Interest Income/Expense	1.07% 0.758	0.75	0.722	0.689	0.697
Depreciation and Amortization	426.51K% 110.92	0.026	0.027	0.028	52.97
Operating Income/Loss	9.46% -8.598	-7.855	-7.855	-9.536	-8.723
Nonoperating Income/Loss	18.75% -0.532	-0.448	-0.509	-0.478	-0.537
Income/Loss From Continuing Operations Before Tax	9.96% -9.13	-8.303	-8.364	-10.01	-9.26
Income/Loss From Continuing Operations After Tax	9.96% -9.13	-8.303	-8.364	-10.01	-9.26
Net Income/Loss	9.96% -9.13	-8.303	-8.364	-10.01	-9.26
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	178.39% -48.42	61.77	47.83	42.00	0.1322
Diluted Average Shares	178.39% -48.42	61.77	47.83	42.00	0.1322
Basic Earnings Per Share	12,085% -15.84	-0.13	-0.17	-0.24	-0.22
Diluted Earnings Per Share	12,085% -15.84	-0.13	-0.17	-0.24	-0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-